The pharmaceutical landscape for diabetes is shifting, and these patches represent a promising development. Unlike subcutaneous injections, this method offers a simpler way to provide GLP-1 therapies. These devices gradually release the medication through the epidermis offering a consistent level of the therapeutic agent, which can enhance gluco… Read More